ClinicalTrials.govpublic full text
Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)
small-for-size syndrome, living donor liver transplantation, ldlt, small-for-size graft, sfs, portal flow modulation, graft inflow modulation, octreotide, somatostatin analogue, splenic artery ligation,, sal, randomized controlled trial
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 828580
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.